Fundraising Fox
Solius Labs
Bainbridge Island, US · Delaware corporation · 1 known investors
Find your way into Solius Labs
Sign up to see every warm intro you have to Solius Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solius Labs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.
Founders & leadership
CK
Chris KipleChief Executive OfficerChris Kiple is Chief Executive Officer of Solius Labs, which develops medical light therapy devices, and Chair of the Board at Lungpacer Medical. He previously served as CEO of Ventec Life Systems for nearly six years, where he led the company through significant growth and oversaw development of the VOCSN Multi-Function Ventilator; earlier in his career, he worked in finance at J.P. Morgan, law at Sidley Austin, and government affairs at Husch Blackwell. He holds a degree in International Affairs and a law degree from George Washington University.
RW
Robert WiseExecutive
AM
Alexander MoffatExecutive
RH
Rick HennesseyInvestor2013–2019Rick Hennessey has built and sold five technology companies and held leadership roles at public firms traded on the NYSE and NASDAQ. He is a co-founder of Cequint, a mobile technology firm that commercialized CallerID technology and was sold for over $100 million; through a family office, he invests in medtech, fintech, and real estate ventures.
DG
Dave GoodChief Special Projects Officer
Board
Investors · 1
Lauder Partnerslisted by Lauder PartnersLos Altosvia Gary Lauder · inferred
How we know: Lauder Partners's portfolio page · offering press articles · Not right? Tell us
Funding
SEC filings, press & company announcements$53.9M disclosed across 5 rounds · 2014–2026
- $23MraisedJun 2026Source ↗
▶$3.5MraisedMay 2026 · 2 investors · Other Health CareRule 506(b)
▶$3.5MraisedMay 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
- Chris KipleExecutive Officer, Director
- Robert WiseExecutive Officer
- Brett ParentDirector
- Scott HirschDirector
- David GoodExecutive Officer
- Christopher AckerleyDirector
- Rick WhiteDirector
- Offering amount
- $17.9M
- Amount sold
- $3.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedMay 2026 · 11 investors · Other Health CareRule 506(b)
▶$23.5MraisedMay 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rick WhiteDirector
- Brett ParentDirector
- Scott HirschDirector
- Robert WiseExecutive Officer
- David GoodExecutive Officer
- Chris KipleExecutive Officer, Director
- Christopher AckerleyDirector
- Offering amount
- $23.5M
- Amount sold
- $23.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$788.2KraisedOct 2018 · 4 investors · Other TechnologyRule 506(b)
▶$788.2KraisedOct 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brett R ParentDirector
- Elwood Denison HowseDirector
- Rick J. HenneseyExecutive Officer, Director
- William Alexander MoffatDirector
- Bob WiseExecutive Officer
- Christopher H AckerleyDirector
- Offering amount
- $12.8M
- Amount sold
- $788.2K
- Sales commissions
- $5K
- Placement agents
- Capital Suisse LLC
- First sale
- Oct 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.1MraisedDec 2015 · 23 investors · Other TechnologyRule 506(b)
▶$3.1MraisedDec 2015 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander MoffatExecutive Officer, Director, Promoter
- Elwood HowseDirector
- Rick HennesseyExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $3.1M
- Minimum investment
- $10K
- First sale
- Nov 2014
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Solius Labs went on to found or lead other companies.
Related companies · 3
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
RoRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.
UclahealthUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
Companies working in the same space as Solius Labs.
In the news
Frequently asked questions
- What does Solius Labs do?
- Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.
- Who are Solius Labs's investors?
- Solius Labs's investors include Lauder Partners.
- How much funding has Solius Labs raised?
- Solius Labs has disclosed $53.9M raised across 5 rounds.
- Where is Solius Labs headquartered?
- Solius Labs is headquartered in Bainbridge Island, US.